Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Classical Hodgkin's lymphoma: past, present and future perspectives.

Eyre TA. et al, (2013), Br J Hosp Med (Lond), 74, 612 - 618

Pharmacokinetics of orally administered rucaparib in patients with advanced solid tumors.

Shapiro G. et al, (2013), MOLECULAR CANCER THERAPEUTICS, 12

Current treatment and future prospects for peripheral T-cell lymphoma.

Eyre TA. and Collins GP., (2013), Drugs Today (Barc), 49, 631 - 646

Practical management of patients with myelofibrosis receiving ruxolitinib.

Harrison C. et al, (2013), Expert Rev Hematol, 6, 511 - 523

Results of restaging oesophageal and junctional cancer after neoadjuvant chemotherapy with PET-CT alone

Findlay J. et al, (2013), BRITISH JOURNAL OF SURGERY, 100, 46 - 46

Routine staging endoscopic ultrasound is not required for T2-T4a oesophageal/junctional cancer

Findlay J. et al, (2013), BRITISH JOURNAL OF SURGERY, 100, 45 - 45

Immune Thrombocytopenia (ITP)

Psaila B. and Bussel JB., (2013), Platelets, 819 - 833

Directed phenotype switching as an effective antimelanoma strategy.

Sáez-Ayala M. et al, (2013), Cancer Cell, 24, 105 - 119